• Home
  • Search Results
  • microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.

microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.

European journal of cancer (Oxford, England : 1990) (2014-07-09)
Jing Hu, Yongxia Cheng, Yuezhen Li, Zaishun Jin, Yanming Pan, Guibo Liu, Songbin Fu, Yafang Zhang, Kejian Feng, Yukuan Feng
ABSTRACT

Recent studies have indicated that microRNAs (miRNAs) are important gene regulators that play critical roles in biological processes and function as either tumour suppressors or oncogenes. Therefore, the expression levels of miRNAs can be important and reliable biomarkers for cancer detection and prognostic prediction, and potentially serve as targets for cancer therapy. In this study, we showed that the expression level of miR-128 was significantly downregulated in non-small cell lung cancer (NSCLC) tissues and cancer cells, and was significantly correlated with NSCLC differentiation, pathological stage and lymph node metastasis. Ectopic miR-128 overexpression significantly suppressed in vitro proliferation, colony formation, immigration and invasion, and induced G1 arrest and apoptosis of NSCLC cells. Interestingly, ectopic miR-128 overexpression could significantly inhibit vascular endothelial growth factor (VEGF)-C expression and reduce the activity of a luciferase reporter containing the VEGF-C 3'-untranslated region. In addition, overexpression of miR-128 in NSCLC cells and human umbilical vein endothelial cells (HUVECs) cells led to decreased expression of VEGF-A, vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3, critical factors responsible for cancer angiogenesis and lymphangiogenesis, and subsequently decreased phosphorylation of extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (AKT) and p38 signalling pathways. Furthermore, in vivo restoration of miR-128 significantly suppressed tumourigenicity of A549 cells in nude mice and inhibited both angiogenesis and lymphangiogenesis of tumour xenografts. These findings suggest that miR-128 could play a role in NSCLC tumourigenesis at least in part by modulation of angiogenesis and lymphangiogenesis through targeting VEGF-C, and could simultaneously block ERK, AKT and p38 signalling pathways. Therapeutic strategies to restore miR-128 in NSCLC could be useful to inhibit tumour progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Monoclonal Anti-Synaptophysin antibody produced in mouse, clone SVP-38, ascites fluid
Sigma-Aldrich
Monoclonal Anti-VEGF antibody produced in mouse, clone 3F7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-Synaptophysin antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-AKT antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-Vascular Endothelial Growth Factor antibody produced in goat, IgG fraction of antiserum, lyophilized powder
Sigma-Aldrich
Anti-AKT antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-AKT1 (pSer473) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-p38 MAP Kinase antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-Vascular Endothelial Growth Factor antibody produced in mouse, clone 26503, purified immunoglobulin, lyophilized powder
Sigma-Aldrich
Anti-AKT1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-2 antibody produced in mouse, clone KDR-1, ascites fluid
Sigma-Aldrich
Anti-SYP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-VEGFR2 (Ab-1059) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-VEGFR-2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
ANTI-VEGFC antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
MONOCLONAL ANTI-VEGFR3 antibody produced in mouse, clone 818CT12.1.1, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-Synaptophysin antibody, Mouse monoclonal, clone SVP-38, purified from hybridoma cell culture
Sigma-Aldrich
ANTI-MAPK3 antibody produced in mouse, clone 1E2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-phospho-Akt (pSer473) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Akt (pThr308) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-p38 MAPK (pTyr182) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-MNK1 (pThr255) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-AKT1 (pThr308) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Mnk1 (pThr385) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Akt1 (pThr450) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Akt (pSer124) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Akt (pTyr474) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Akt (pSer129) antibody produced in rabbit, affinity isolated antibody